Unknown

Dataset Information

Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD.


ABSTRACT: Adults with attention deficit hyperactivity disorder (ADHD) have shown higher infection rates and worse outcomes from COVID-19. Stimulant medications are prescribed as the first-line treatment for ADHD in adults and mitigate risk of negative ADHD-related health outcomes, but little is known about the association between stimulant medications and COVID-19 outcomes. The objective of this study was to assess the risks of severe COVID-19 outcomes among people with ADHD who were prescribed stimulant medications versus those who were not. This retrospective cohort study used electronic health records in the TriNetX research database. We assessed records of adults with ADHD diagnosed with COVID-19 between January 1, 2020 and June 30, 2021. The stimulant cohort consisted of 28,011 people with at l

SUBMITTER: Tuan WJ 

PROVIDER: S-EPMC9279163 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature